Authors: Karjalainen, JM Kellokoski, JK Mannermaa, AJ Kujala, HE Moisio, KI Mitchell, PJ Eskelinen, MJ Alhava, EM Kosma, VM

Citation: Jm. Karjalainen et al., Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 alpha in cutaneous melanoma, BR J CANC, 82(12), 2000, pp. 2015-2021

Authors: Karjalainen, JM Tammi, RH Tammi, MI Eskelinen, MJ Agren, UM Parkkinen, JJ Alhava, EM Kosma, VM

Citation: Jm. Karjalainen et al., Reduced level of CD44 and hyaluronan associated with unfavorable prognosisin clinical stage I cutaneous melanoma, AM J PATH, 157(3), 2000, pp. 957-965

Authors: Karjalainen, JM Eskelinen, MJ Kellokoski, JK Reinikainen, M Alhava, EM Kosma, VM

Citation: Jm. Karjalainen et al., p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival, BR J CANC, 79(5-6), 1999, pp. 895-902

Authors: Karjalainen, JM Eskelinen, MJ Nordling, S Lipponen, PK Alhava, EM Kosma, VM

Citation: Jm. Karjalainen et al., Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma, BR J CANC, 77(11), 1998, pp. 1917-1925